HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of virus-inactivated plasma in apheresis treatment of thrombotic thrombocytopenic purpura: preliminary data].

Abstract
Plasma exchange (TPEx) with fresh frozen plasma (FFP) or cryosupernatant plasma infusion is the treatment of choice for thrombotic thrombocytopenic purpura (TTP). The authors evaluate the preliminary data of the multicenter SIdEM study that compares virus-inactivated plasma with fresh frozen plasma (FFP) or cryosupernatant plasma in the apheretic treatment of TTP.
AuthorsGianpaolo Russi, Giustina De Silvestro, Chiara Savignano, Gruppo di Studio Multicentrico PTT SldeM
JournalGiornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia (G Ital Nefrol) 2012 Jan-Feb Vol. 29 Suppl 54 Pg. S49-53 ISSN: 0393-5590 [Print] Italy
Vernacular TitlePlasma virus-inattivato nella terapia aferetica della porpora trombotica trombocitopenica: studio e dati preliminari.
PMID22388830 (Publication Type: English Abstract, Journal Article, Multicenter Study)
Topics
  • Evidence-Based Medicine
  • Female
  • Humans
  • Italy
  • Male
  • Plasma
  • Plasma Exchange
  • Plasmapheresis (methods)
  • Purpura, Thrombotic Thrombocytopenic (therapy)
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Virus Inactivation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: